Many prognostic factors are lacking: hormone receptors, Her2 neu, Ki67, etc.; we really need to think about all this and improve, especially because of the younger age of women with breast cancer in our environment; screening may start at 40 years instead of 50 in our milieu. Here, ERBB2 is linked to breast carcinoma.